Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
367
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
-1.62M
-
Total reported value, excl. options
-
$6B
-
Value change
-
-$219M
-
Put/Call ratio
-
7.25
-
Number of buys
-
181
-
Number of sells
-
-183
-
Price
-
$129.73
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2017
450 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2017.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 367 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
.
Largest 10 shareholders include BlackRock Inc. (4.9M shares), FMR LLC (4.25M shares), VANGUARD GROUP INC (3.81M shares), AQR CAPITAL MANAGEMENT LLC (2.19M shares), STATE STREET CORP (2.01M shares), Palo Alto Investors, LLC (1.87M shares), GOLDMAN SACHS GROUP INC (1.58M shares), ACADIAN ASSET MANAGEMENT LLC (1.14M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.09M shares), and RENAISSANCE TECHNOLOGIES LLC (838K shares).
This table shows the top 367 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.